A Synergy Unit, in which Helmholtz Munich is involved, will develop, deploy, and connect foundation models.
In a new collaboration, the Computational Health Center at Helmholtz Munich has teamed up with the global pharmaceutical company Pfizer. The joint initiative, spanning three years, aims to leverage Pfizer's vast knowledge and accumulated data in…
An interview with Prof. Fabian Theis, Head of the Computational Health Center, and Prof. Bjoern Eskofier, Group Leader for Translational Digital Health. The researchers hosted the first Munich Health Foundation Model Symposium on April 10, 2024, at…
Helmholtz Munich is bringing together a wide range of experts to advance the development of foundation models focused on health research. The Munich Health Foundation Model Symposium, to be held on April 10, 2024, at the Helmholtz Munich Campus, aims…
The genetic information in our cells harbors secrets about the risks, progression, and complications of many diseases. With hundreds of millions of patients worldwide, identifying and understanding genetic risk for type 2 diabetes is of particular…
Therapeutic antibodies play a crucial role in treating diseases by modifying immune cells. Scientists from the Institute of AI for Health at Helmholtz Munich in collaboration with Roche present an open-source framework for comprehensive antibody…
We use cookies to improve your experience on our Website. We need cookies to continually improve our services, enable certain features, and when we embed third-party services or content, such as the Vimeo video player. In such cases, information may also be transferred to third parties. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here: